Format

Send to:

Choose Destination
See comment in PubMed Commons below
Leukemia. 2014 May;28(5):1158-63. doi: 10.1038/leu.2014.9. Epub 2014 Jan 13.

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.

Author information

  • 1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • 2Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
  • 3Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
  • 4Karyopharm Therapeutics Inc., Natick, MA, USA.
  • 51] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA [2] Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
PMID:
24413321
[PubMed - indexed for MEDLINE]
PMCID:
PMC4013224
[Available on 2015-05-01]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk